InflaRx (IFRX)
(Delayed Data from NSDQ)
$1.39 USD
+0.03 (2.21%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.41 +0.02 (1.44%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for InflaRx NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 1 | 0 | 0 | 0 | 0 |
Gross Profit | -1 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 62 | 55 | 56 | 39 | 63 |
Income After Depreciation & Amortization | -63 | -55 | -56 | -39 | -63 |
Non-Operating Income | 17 | 24 | 2 | 0 | 7 |
Interest Expense | 0 | 0 | 0 | 0 | 3 |
Pretax Income | -46 | -31 | -54 | -39 | -60 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -46 | -31 | -54 | -39 | -60 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -46 | -31 | -54 | -39 | -60 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -62 | -55 | -56 | -38 | -63 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -63 | -55 | -56 | -39 | -63 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 54.94 | 44.21 | 41.63 | 27.07 | 26.01 |
Diluted EPS Before Non-Recurring Items | -0.84 | -0.71 | -1.30 | -1.44 | -2.29 |
Diluted Net EPS (GAAP) | -0.84 | -0.71 | -1.30 | -1.44 | -2.30 |
Fiscal Year end for InflaRx NV falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.07 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.30 | 0.28 | 0.00 | 0.00 |
Gross Profit | NA | -0.30 | -0.21 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.84 | 12.80 | 16.07 | 19.68 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -14.14 | -13.01 | -16.07 | -19.68 |
Non-Operating Income | NA | -3.07 | 4.91 | 7.13 | 7.80 |
Interest Expense | NA | 0.02 | 0.01 | 0.01 | 0.01 |
Pretax Income | NA | -17.23 | -8.11 | -8.94 | -11.90 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -17.23 | -8.11 | -8.94 | -11.90 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -17.23 | -8.11 | -8.94 | -11.90 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 56.89 | 58.88 | 56.99 | 44.77 |
Diluted EPS Before Non-Recurring Items | NA | -0.30 | -0.14 | -0.15 | -0.27 |
Diluted Net EPS (GAAP) | NA | -0.28 | -0.14 | -0.15 | -0.27 |